BCAT1 and cholangiocarcinoma: Overexpression of BCAT1 was detected in 10 cancers, containing breast invasive carcinoma (BRCA), cholangiocarcinoma (CHOL), esophageal carcinoma (ESCA), glioblastoma multiforme, HNSCC, kidney chromophobe, kidney renal clear cell carcinoma (KIRC), liver hepatocellular carcinoma (LIHC), stomach adenocarcinoma (STAD), and thyroid carcinoma (THCA; Figure 2C).